American Renal Associates Holdings, Inc (NYSE:ARA) shares hit a new 52-week low during trading on Thursday . The company traded as low as $14.10 and last traded at $14.01, with a volume of 195,426 shares trading hands. The stock had previously closed at $15.40.

ARA has been the topic of a number of recent research reports. Zacks Investment Research upgraded shares of American Renal Associates Holdings from a “sell” rating to a “hold” rating in a research report on Wednesday, May 10th. Wells Fargo & Company upgraded shares of American Renal Associates Holdings from a “market perform” rating to an “outperform” rating in a research report on Thursday, May 11th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and five have issued a buy rating to the stock. American Renal Associates Holdings has an average rating of “Buy” and a consensus price target of $25.50.

The firm’s 50 day moving average price is $17.63 and its 200-day moving average price is $18.18. The company’s market capitalization is $446.82 million.

American Renal Associates Holdings (NYSE:ARA) last released its quarterly earnings data on Tuesday, August 8th. The company reported $0.16 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.12 by $0.04. American Renal Associates Holdings had a positive return on equity of 18.26% and a negative net margin of 1.54%. The business had revenue of $185.99 million for the quarter, compared to the consensus estimate of $188.23 million. The company’s revenue was up .2% on a year-over-year basis. On average, equities research analysts forecast that American Renal Associates Holdings, Inc will post $0.54 EPS for the current year.

Several institutional investors have recently added to or reduced their stakes in ARA. Martingale Asset Management L P increased its position in American Renal Associates Holdings by 60.9% in the second quarter. Martingale Asset Management L P now owns 35,417 shares of the company’s stock valued at $657,000 after buying an additional 13,412 shares in the last quarter. Alliancebernstein L.P. increased its position in American Renal Associates Holdings by 3.0% in the second quarter. Alliancebernstein L.P. now owns 13,900 shares of the company’s stock valued at $258,000 after buying an additional 400 shares in the last quarter. Wells Fargo & Company MN increased its position in American Renal Associates Holdings by 21.1% in the second quarter. Wells Fargo & Company MN now owns 14,482 shares of the company’s stock valued at $268,000 after buying an additional 2,520 shares in the last quarter. TimesSquare Capital Management LLC increased its position in American Renal Associates Holdings by 6.7% in the second quarter. TimesSquare Capital Management LLC now owns 1,290,200 shares of the company’s stock valued at $23,933,000 after buying an additional 80,650 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its position in American Renal Associates Holdings by 2,089.4% in the second quarter. JPMorgan Chase & Co. now owns 72,250 shares of the company’s stock valued at $1,340,000 after buying an additional 68,950 shares in the last quarter. 90.93% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: This article was originally published by Watch List News and is the property of of Watch List News. If you are reading this article on another publication, it was illegally stolen and republished in violation of United States & international copyright and trademark law. The correct version of this article can be read at https://www.watchlistnews.com/american-renal-associates-holdings-inc-nyseara-reaches-new-12-month-low-at-14-10/1469935.html.

American Renal Associates Holdings Company Profile

American Renal Associates Holdings, Inc is a dialysis service provider in the United States focused on joint venture (JV) partnerships with physicians. As of December 31, 2016, the Company owned and operated 214 dialysis clinics in partnership with 379 nephrologist partners treating over 14,000 patients in 25 states and the District of Columbia.

Receive News & Ratings for American Renal Associates Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Renal Associates Holdings Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.